1-20 of 49
Keywords: Sorafenib
Close
Sort by
Journal Articles
Journal Articles
Subject Area:
Oncology
Journal: Oncology
Oncology (2024) 102 (3): 239–251.
Published Online: 20 September 2023
...; Yasuyuki Aisaka; Keiichi Masaki; Yohji Honda; Noriaki Naeshiro; Akira Hiramatsu; Hiroshi Aikata; Shiro Oka Introduction: Systemic therapy is recommended for patients with Child-Pugh A in hepatocellular carcinoma (HCC). We analyzed the outcomes of a cohort of patients with HCC who received either sorafenib...
Journal Articles
Journal Articles
Subject Area:
Oncology
Journal: Oncology
Oncology (2020) 98 (9): 621–629.
Published Online: 20 May 2020
... the outcomes of systemic therapy in HCC with bile duct invasion. Objective: Our aim was to clarify the efficacy and safety of sorafenib treatment in patients with unresectable advanced HCC with bile duct invasion. Methods: One hundred and seventy-five patients with advanced HCC were enrolled in this study. We...
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Subject Area:
Oncology
Journal: Oncology
Oncology (2018) 94 (4): 215–222.
Published Online: 09 February 2018
...; Hirotaka Kohno; Hiroshi Kohno; Takashi Moriya; Michihiro Nonaka; Hideyuki Hyogo; Yasuyuki Aisaka; Tomoki Kimura; Yasushi Nagata; Kazuaki Chayama Objective: To compare the outcome of hepatic arterial infusion chemotherapy combined with radiotherapy (HAIC + RT) versus sorafenib monotherapy in patients...
Journal Articles
Journal Articles
Subject Area:
Oncology
Journal: Oncology
Oncology (2017) 93 (Suppl. 1): 113–119.
Published Online: 20 December 2017
... Deguchi; Yasutaka Kokudo; Yasunori Minami; Kazuomi Ueshima; Toshiharu Sakurai; Naoshi Nishida; Masatoshi Kudo Objective: To determine the relationship between treatment outcomes and hand-foot syndrome (HFS), and the relationship between survival rate and post-progression treatment after sorafenib therapy...
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Subject Area:
Oncology
Journal: Oncology
Oncology (2015) 89 (2): 88–94.
Published Online: 02 April 2015
...Maria-Katharina Ganten; Max Schuessler; Thomas Bruckner; Tom M. Ganten; Ronald Koschny Objective: To date, sorafenib is the only approved systemic therapy for advanced hepatocellular carcinoma (HCC). Pancreatic atrophy has recently been reported in 2 patients as a novel side effect after long-term...
Journal Articles
Journal Articles
Journal Articles
Subject Area:
Oncology
Journal: Oncology
Oncology (2015) 88 (4): 241–246.
Published Online: 11 December 2014
... or intolerant to sorafenib and to exclude unsuitable candidates from subsequent therapy. Methods: The study cohort consisted of 111 patients who had discontinued sorafenib therapy. Uni- and multivariate analyses were conducted to identify the prognostic factors for survival after discontinuation of sorafenib...
Journal Articles
Journal Articles
Journal Articles